Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Medicenna Therapeutics Corp. MDNA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score
61/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Medicenna Therapeutics Corp. (MDNA) has 12 identified peers for comparison in the Healthcare sector. Peers include ACHL, AKTX, APVO, CKPT, CNTB, CUE and others.

People Also View

EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.70
+1.63%
 IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
 OVID
OVID
Ovid Therapeutics Inc.
$2.76
-6.76%
 MNPR
MNPR
Monopar Therapeutics Inc.
$57.91
-0.02%
 CKPT
CKPT
Checkpoint Therapeutics, Inc.
$4.26
+0.00%
 ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
 SRZN
SRZN
Surrozen, Inc.
$32.02
+0.53%
 IVVD
IVVD
Invivyd, Inc.
$1.71
+6.21%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message